← All organizations
New York Presbyterian Hospital
Academic/HospitalWebsite ↗
Also known as: Clinic 02 - New York Presbyterian Hospital | Morgan Stanley Children's Hospital | New York Presbyterian | New York Presbyterian Brooklyn Methodist Hospital | New York Presbyterian Hospital | NewYork-Presbyterian Hospital | NYP Institute
Highest phase reached
Phase 4
First clinical trial
Mar 1, 1990Last known activity
Jul 10, 2025
Timeline
1770s
- Jun 1, 1771
New York Presbyterian Hospital— Founded
Drugs by trial phase (47 distinct, 35 trials)
Phase 4 (10 own, 0 via acquisition)
Phase 3 (16 own, 0 via acquisition)
Phase 2 (12 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Other trials (8 own, 0 via acquisition)
Indications
Studied for
- Acquired Immunodeficiency Syndrome
- Alcohol Drinking
- Alcoholism
- Asthma
- Breast Neoplasms
- Carcinoma, Ovarian Epithelial
- Cervical Intraepithelial Neoplasia
- Compulsive Personality Disorder
- Congenital Abnormalities
- Corneal Neovascularization
- Cytomegalovirus Retinitis
- Disease
- Emergencies
- End Stage Liver Disease
- Fibromyalgia
- Headache
- Hepatitis
- Hepatitis A
- Hepatitis C
- Hepatitis C, Chronic
- HIV Infections
- Hypercalciuria
- Hyperplasia
- Hypertension
- Hypertension, Pulmonary
- Hypertrophy
- Immunologic Deficiency Syndromes
- Kidney Calculi
- Kidney Failure, Chronic
- Labor Pain
- Leukemia
- Leukemia, Promyelocytic, Acute
- Liver Diseases
- Myelodysplastic Syndromes
- Myofascial Pain Syndromes
- Nausea
- Neoplasms
- Neovascularization, Pathologic
- Nephrolithiasis
- Obsessive-Compulsive Disorder
- Ovarian Neoplasms
- Preleukemia
- Prostatic Hyperplasia
- Renal Insufficiency
- Respiratory Sounds
- Retinitis
- Somatoform Disorders
- Squamous Intraepithelial Lesions of the Cervix
- Syndrome
- Temporomandibular Joint Disorders
- Temporomandibular Joint Dysfunction Syndrome
- Thrombocytopenia
- Urinary Bladder Neoplasms
- Urolithiasis
- Urologic Diseases
- Uterine Cervical Dysplasia
- Vitamin D Deficiency
- Vomiting
Recent trials (38)
- NCT07073209CollaboratorN/AJul 10, 2025
- NCT06679634CollaboratorPhase 2Nov 30, 2024
- NCT05977400CollaboratorPhase 3Apr 30, 2024
- NCT04924322CollaboratorPhase 2/Phase 3Jan 1, 2022
- NCT04669288CollaboratorPhase 3May 31, 2021
- NCT03223298Overall official - principal investigatorPhase 3Aug 31, 2018
- NCT03223298CollaboratorPhase 3Aug 31, 2018
- NCT03337451CollaboratorPhase 1/Phase 2Feb 27, 2018
- NCT02735577Overall official - principal investigatorPhase 4Mar 1, 2016
- NCT02725008Lead sponsorPhase 3Jul 1, 2015
- NCT02422290CollaboratorPhase 1/Phase 2Mar 1, 2015
- NCT01996826CollaboratorPhase 1/Phase 2Apr 1, 2014
- NCT01763606CollaboratorN/ADec 1, 2012
- NCT01404949CollaboratorPhase 2Jul 1, 2011
- NCT01295879Reponsible party - principal investigatorPhase 4Sep 1, 2010
Details
- Founded
- New York, NY, US Jun 1, 1771
- Last known activity
- Jul 10, 2025